Category: Biopharmaceuticals
Global Biopharmaceuticals
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
Global High Potency APIs Market Size study, by Type (Innovative, Generic), by Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), by Manufacturers (Captive, Merchant), by Application (Oncology, Hormonal Imbalance, Glaucoma) and Regional Forecasts 2022-2032
... global High Potency APIs (HPAPIs) market is currently valued at approximately USD 26.97 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 10.10% during the forecast period from ... Read More
-
Psoriasis Biosimilars Market Forecasts to 2030 – Global Analysis By Product (Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Rituximab Biosimilars, Etanercept Biosimilars and Other Products), Therapy Type, Application, End User and By Geography
... Stratistics MRC, the Global Psoriasis Biosimilars Market is accounted for $10.27 billion in 2024 and is expected to reach $25.31 billion by 2030 growing at a CAGR of 12.2% during the forecast period. Psoriasis biosimilars ... Read More
-
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market 2025-2029
... the forecast period. The report on the biologics contract development and manufacturing organization (CDMO) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around ... Read More
-
Global Avastin (Bevacizumab) Biosimilars Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Avastin (Bevacizumab) is a medication used to treat a number of types of ... Read More
-
Global Avastin (Bevacizumab) Biosimilars Market Growth 2024-2030
... the Avastin (Bevacizumab) Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Avastin (Bevacizumab) ... Read More
-
Global G-CSF Biosimilars Market Growth 2024-2030
... Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global G-CSF Biosimilars market. G-CSF Biosimilars ... Read More
-
Global HGH Biosimilars Market Growth 2024-2030
... Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global HGH Biosimilars market. HGH Biosimilars ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
... (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry ... Read More
-
Global Insulin Biosimilars Market Growth 2024-2030
... Insulin Biosimilars is forecast to a readjusted size of US$ 1858.4 million by 2030 with a CAGR of 3.6% during review period. The research report highlights the growth potential of the global Insulin Biosimilars market. ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Monoclonal antibodies (mAbs) Biosimilars is forecast to a readjusted size of US$ 5256.8 million by 2030 with a CAGR of 2.0% during review period. The research report highlights ... Read More
-
Biologics Contract Development Market Report: Trends, Forecast and Competitive Analysis to 2030
... disorder, cardiovascular disorder, and hematological disorder markets. The global biologics contract development market is expected to reach an estimated $40.9 billion by 2030 with a CAGR of 11.5% from 2024 to 2030. The major drivers ... Read More
-
Global Biosimilars Insulin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Biosimilars is a biological product designed to have similar active properties to the one that ... Read More
-
Rare Disease Treatment Market Assessment, By Drug Type [Biologics, Biosimilars, Small Molecules], By Patient [Adult, Pediatric, Geriatric], By Therapeutic Area [Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, Infectious Diseases, Others], Mode of Administration [Oral, Injectable, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F Global hemophilia market is projected to witness a CAGR of 5.50% during the forecast period 2024-2031, growing from USD ... Read More
-
Global Cell Culture Bioreactors Market Growth 2024-2030
... the Cell Culture Bioreactors is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Cell Culture ... Read More
-
Global Biosimilars and Biologics Market - 2024-2031
... the forecast period 2024- 2031. Biologics are a category of medical products derived from or containing components of living organisms. Unlike traditional pharmaceuticals, typically made through chemical synthesis, biologics are produced using biotechnology, involving complex ... Read More
-
Global Tocilizumab Biosimilars Market Growth 2024-2030
... thereby modulating the inflammatory response. The global Tocilizumab Biosimilars market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from ... Read More
-
Global Ustekinumab Biosimilars Market Growth 2024-2030
... Biosimilars market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030. LP Information, Inc. (LPI) ' ... Read More
-
Biologics Contract Manufacturing Market by Type of Service(s) Offered (API, FDF), Type of Biologic Manufactured (Antibodies, Cell Therapies, Vaccines and Other Biologics), Type of Expression System Used (Mammalian, Microbial and Others), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, Till 2035
... / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, Till 2035 BIOLOGICS CONTRACT MANUFACTURING ... Read More
-
2024 Global Single-Use Bioprocessing Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
Biologics Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global biologics contract manufacturing market is set for remarkable growth, with worldwide revenue anticipated to increase from USD 16.01 billion in 2024 to an impressive USD 36.3 billion by 2031. Projected to grow at ... Read More
-
Single-use Technologies for Biopharmaceuticals: Global Markets
... each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges and opportunities for the market. It provides information on emerging technologies and developments in the industry. It analyzes critical ... Read More
-
Global Biosimilars Market (2nd Edition)
... has experienced significant growth, owing to its improved effectiveness in managing chronic diseases. However, the high costs associated with biologics pose considerable economic and healthcare challenges. As the demand for biologics continues to increase, developers ... Read More
-
Biopharmaceutical Logistics
... at a CAGR of 4.8% over the analysis period 2023-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$37.9 Billion by the end ... Read More
-
Biopharmaceutical Fermentation Systems
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by ... Read More
Research Assistance
